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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYThe salamander is the only tetrapod that functionally regenerates all cell types of the limb and spinal cord (SC) and thus represents an
important regeneration model, but the lack of gene-knockout technology has limited molecular analysis. We compared transcriptional
activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPRs) in the knockout of
three loci in the axolotl and find that CRISPRs show highly penetrant knockout with less toxic effects compared to TALENs. Deletion
of Sox2 in up to 100% of cells yielded viable F0 larvae with normal SC organization and ependymoglial cell marker expression such as
GFAP and ZO-1. However, upon tail amputation, neural stem cell proliferation was inhibited, resulting in spinal-cord-specific regenera-
tion failure. In contrast, the mesodermal blastema formed normally. Sox3 expression during development, but not regeneration, most
likely allowed embryonic survival and the regeneration-specific phenotype. This analysis represents the first tissue-specific regeneration
phenotype from the genomic deletion of a gene in the axolotl.INTRODUCTION
Themolecular study of regeneration in animals such as the
salamander serves as an important basis for understanding
the limited regenerative abilities of other animals. The sal-
amander is the only tetrapod where full cellular reconstitu-
tion of a lesioned spinal cord occurs and where the adult
limb functionally regenerates all constituent tissues, and
it therefore plays particular significance in understanding
regenerative ability and how it may be improved (Kragl
et al., 2008, 2009; Simon and Tanaka, 2013; Tanaka and
Ferretti, 2009). The relevance of salamander regeneration
to mammals was highlighted in an analysis of mouse digit
tip regeneration, which showed that the molecular factors
mediating tissue interactions between nerve and skin were
similar to those first identified during salamander limb
regeneration (Takeo et al., 2013). Furthermore, the exten-
sive skin-regenerative capacities of the spiny mouse were
shown to utilize an extracellular matrix (ECM) environ-
ment similar to those defined for salamander limb re-
generation, suggesting that the implementation of certain
ECM-expression programs is associated with deep regener-
ative ability (Seifert et al., 2012). Therefore, deepening our
understanding of the molecular programs underlying the
regenerative response in salamanders is an important
endeavor.
Targeted overexpression of genes via electroporation,
viral transduction, or transgenesis as well as knockdown
of protein expression via electroporation morpholinos,
respectively, has been an important means of molecularly
analyzing regeneration in the axolotl (Echeverri and444 Stem Cell Reports j Vol. 3 j 444–459 j September 9, 2014 j ª2014 The ATanaka, 2005; Kawakami et al., 2006; Khattak et al., 2013;
Mercader et al., 2005; Roy et al., 2000; Whited et al.,
2013). However, the lack of stable genomic knockout in
the axolotl had limited molecular studies. Recently,
exciting progress has been made on genome editing using
zinc-finger nucleases, transcriptional activator-like effector
nucleases (TALENs), and clustered regularly interspaced
short palindromic repeat (CRISPR) systems (for review,
see Gaj et al., 2013). With these methods, highly efficient
gene knockout or homologous gene knockin has been
achieved in a variety of species including vertebrates such
as Xenopus, zebrafish, and rodents. Studies implementing
TALENs in Xenopus reported that targeted deletions reach
efficiencies up to 100% of alleles (Lei et al., 2012; Suzuki
et al., 2013). The effectiveness of TALENs was also recently
demonstrated in the ribbed Iberian newt, Pleurodeles waltl
(Hayashi et al., 2014). These results indicate that TALENs
are a highly versatile system for targeting deletions and
gene insertions into vertebrate genomes.
Recently, an alternative method of genome editing was
described, based on nucleases of the bacterial antiphage
‘‘immune’’ system, CRISPR (for review, see Gaj et al.,
2013; Mali et al., 2013a). Several groups engineered a
two-component system for genome editing in which a sin-
gle guide RNA (gRNA) was coexpressed with the Cas9 gene
(Cong et al., 2013; Jinek et al., 2012; Mali et al., 2013b).
This two-component system resulted in highly efficient
generation of indels at the target site. In human embryonic
stem cells, depending on the target, 1%–34% of expressing
cells showed a deletion of at least one targeted allele. The
method has also been used to demonstrate the possibilityuthors
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including the axolotl (Blitz et al., 2013; Flowers et al., 2014;
Hwang et al., 2013; Nakayama et al., 2013).
In most vertebrate models, mRNAs encoding TALENs
and CRISPRs have been injected into the egg to generate
genomic deletions from the beginning of development.
Since regeneration is a late event, a question is whether
this means of knocking out genes can be applied to study-
ing specific cell types during regeneration or whether more
sophisticated methods to induce knockouts later in devel-
opment will be necessary. Here, we investigated the utility
of the CRISPR system to knock out a key neural stem gene,
Sox2, with the aim to study its role in the regenerating spi-
nal cord. SOX2 is an SRY-related high-mobility group box
transcription factor that supports embryonic pluripotency
(Avilion et al., 2003), and it later plays a key role in
the development, maintenance, and expansion of neural
stem/progenitor cells (Bylund et al., 2003; Favaro et al.,
2009; Takemoto et al., 2011). In addition, Sox2 is required
to maintain the proliferative progenitor pool in various
adult epithelia (Arnold et al., 2011; Que et al., 2009). In
the axolotl, SOX2 is expressed in the mature spinal cord
and in cultured spinal cord neurospheres that harbor mul-
tipotent neural stem cells that reconstitute the different
spinal cord cell types (McHedlishvili et al., 2012; Tapia
et al., 2012). The molecular factors that support the rapid
expansion and self-renewal of neural stem cells during spi-
nal cord regeneration after tail amputation were unknown.
Here, we show by the CRISPR-mediated genomic deletion
of Sox2 that axolotls harboring up to 100% Sox2 deleted
cells survive embryonic development to generate larvae
with a normal spinal cord cell complement and neuronal
number. Morpholino knockdown of SOX2 in the embryo
confirms lack of embryonic lethality. Upon tail amputa-
tion, however, the spinal cord cells do not increase their
proliferation, resulting in defective expansion and an over-
all lack of spinal cord in the regenerating tail. Expression
analysis of Sox3 shows overlapping expression with Sox2
during neural tube development, but not regeneration,
rationalizing the spinal cord regeneration-specific pheno-
type. Despite severe defects in the regenerating spinal
cord, the regenerative epidermis and the mesenchymal
blastema form normally in Sox2-CRISPR animals.RESULTS
CRISPRs Mediate More Efficient, Less Toxic Gene
Knockout Than TALENs in Axolotl
Germline-Transmitted Knockout of a GFP-Transgene
To determine if TALENs and CRISPRs can mediate efficient
gene deletions, we initially chose to knock out a genomi-
cally inserted GFP-transgene in our germline-transgenicStem CellGFP-axolotl strain (Sobkow et al., 2006) to have an easy
readout for successful gene knockout. Two pairs of GFP-
TALENs and two pairs of CRISPRGFP-gRNAs in correspond-
ing regions were designed according to published protocols
(Cermak et al., 2011; Cong et al., 2013; Mali et al., 2013b)
(Figures 1A–1A0 0; see the Experimental Procedures). We in-
jected the TALEN mRNAs (mixture of left- and right-arm
mRNAs) or CRISPR RNAs (mixture of Cas9 mRNA and
GFP-gRNA) into freshly laid axolotl embryos with the aim
of elicitingknockoutof thegenomicGFPas early aspossible.
In the egg injection experiments, we titrated the amount of
injected TALEN (Table S1 available online) and CRISPR
(Table S2) RNAs and found that the CRISPR RNAs were
significantly less toxic to embryos (evaluated at 10 days
postinjection) (Tables S1 and S2). We next assessed the effi-
ciency of genomic modification. Injections of GFP-TALEN
pair #1 or #3 mRNA, but not control TALENs (#1 left-arm
plus #3 right-arm mRNAs), into embryos resulted in 24%–
34% of the larvae showing a visible loss or reduction of
GFP expression in at least some tissue/body cells in the
resulting larvae (Figures 1B and C; Table S3). GFP expres-
sion was markedly reduced in the normally strongly ex-
pressingmuscle, as confirmedonhistological cross-sections
(Figure 1C). The genomic generation of indels was con-
firmed by genomic PCR (Figure 1D). Animals modified by
GFP-TALENs #1 and #3 were grown to adulthood, and
both showed germline transmission of the GFP deletion
with a representative transmission frequency of 56%.
In comparison to TALENs, injection of CRISPRGFP-gRNA
#3 generated GFP deletions at a higher penetrance and effi-
ciency. A total of 55% of injected animals showed at least
some loss ofGFP expression. Of the animals showingmodi-
fication, 60% showed greater than 50% of cells lacking GFP
expression (Table S3; Figures 1E–1F0 0). Control CRISPR
Tyrosinase(Tyr)-gRNA did not yield knockdown of GFP
expression (Figures 1G–1G0 0). Cryosections confirmed the
loss of GFP expression in GFP-gRNA#3-injected, but not
control Tyr-gRNA#1-injected, animals at the cellular level
(Figure 1H). Finally, PCR cloning and sequencing of
genomic DNA isolated from individual injected animals
showed a large proportion of clones (cells) with deletions
at the targetGFP sequence (Figure 1I). Control-injected em-
bryos showed no modification of the GFP locus. Germline
transmission of CRISPRs is still to be determined. In sum-
mary, our results showed that GFP-TALENs and GFP-
CRISPRs can successfully modify the GFP-transgene, with
CRISPR mediating more efficient, less toxic effects.
Efficient Knockout of the Endogenous Tyrosinase Gene
To assess the effectiveness of TALENs and CRISPRs on an
endogenous gene, we first chose the axolotl Tyrosinase
(Tyr) gene as it is a nonessential gene whose knockout gives
a clear, pigmentation defect. To knock out Tyr, two pairs
of Tyr-TALENs (#3 and #4) and three CRISPR gRNAsReports j Vol. 3 j 444–459 j September 9, 2014 j ª2014 The Authors 445
Figure 1. Deletions in a GFP-Transgene in the Axolotl Genome via TALEN or CRISPR Injections
(A–A0 0) TALENs (green) and CRISPR gRNAs (red) were designed to target the GFP sequence and injected into one-cell-stage eggs.
(B) Representative axolotl larvae that received GFP-TALEN #3 in which half of the body (red arrow compared to green arrow) has lost GFP
expression. Control (GFP-TALEN #1 left-arm plus #3 right-arm mRNAs) injection showed bilaterally symmetric GFP expression (green
arrows). Scale bar, 2 mm.
(C) Tail cross-sections from GFP-TALEN #3 knockdown versus control knockdown animals counterstained for DAPI and muscle-specific
myosin heavy chain (MHC) immunostaining. GFP fluorescence signal is missing in muscle cells of the GFP-TALEN section, but not in a
comparable region of the control animal. Region of interest is shown and zoomed by the white box. Scale bar, 200 mm.
(legend continued on next page)
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CRISPR-Mediated Sox2 Deletion in Axolotl(Figure 2A) were assessed by injection of RNAs into em-
bryos and examined 13 days postinjection (Table S4). A to-
tal of 60% of animals injected with Tyr-TALEN #4 mRNA
showed at least some loss of pigment in the body (Figures
2B and 2B0). In comparison, the most efficient CRISPR
Tyr-gRNA#1 yielded 99% of animals showing loss in
pigment, with 86% showing apparently complete loss of
pigment (Table S4; Figures 2E and 2E0). Animals injected
with control TALEN (left arm of Tyr-TALEN #4) and GFP-
gRNA#3 showed no loss in pigmentation (Figures 2C,
2C0, 2F, and 2F0). Again, PCR amplification, cloning, and
sequencing of the target Tyr sequence showed a higher
rate of deletions from Tyr-CRISPR (Figure 2G) when
compared to Tyr-TALEN (Figure 2D). Our results show
that for two independent gene-knockout trials, CRISPRs
showed a higher frequency and penetrance of gene knock-
down with less animal lethality compared to TALENs.
Axolotls Harboring CRISPR-Mediated Deletions in
Sox2 ShowNormal Size andOrganization of the Spinal
Cord during Development
Given the higher success rate with CRISPRs, we sought to
determine the role of Sox2 in axolotl spinal cord develop-
ment and regeneration by the generation of CRISPR-medi-
ated gene deletions. In axolotls, SOX2 expression was asso-
ciated with neural stem cells that have the ability to
clonally reconstitute spinal cord cell types during tail
regeneration (McHedlishvili et al., 2012). In order to effec-
tively disrupt the protein-coding sequence of Sox2, seven
CRISPR targeting sites were selected as close as possible to
the translational start codon (Figures 3A and 3B). Sox2-
CRISPR RNAs were injected into fertilized eggs at the sin-
gle-cell stage and analyzed 13 days postinjection. Of the
seven Sox2-gRNAs designed, two of them, Sox2-gRNA#2
targeting the N-terminal region and Sox2-gRNA#4 target-
ing the middle of the sequence, gave identical, penetrant
phenotypes described below, while a smaller proportion
of Sox2-gRNA#5-injected animals gave a milder version of(D) Analysis of genomic target site in two individuals injected with G
of 9 out of 15 clones showed deletions or deletions plus insertions in t
in the cells.
(E) Representative axolotl larva that received CRISPR GFP-gRNA#3 in
(E0) GFP expression is reduced throughout the body.
(E0 0) High-magnification view of tail tissue. Only a few remaining GFP
(F–F0 0) Another representative axolotl larva with extensive knockout
(G–G0 0) Injection of CRISPR gRNAs targeting the axolotl Tyrosinase (
Scale bars represent 1 mm in (E) and 500 mm in (E0 0).
(H) Tail cross-sections from CRISPR GFP knockdown versus control
immunostaining. GFP fluorescence signal is missing in most cells of t
(I) Analysis of genomic target site in two individuals injected with G
samples, all 12 clones showed deletions or deletions plus insertions
cation in the cells.
See also Tables S1–S3.
Stem Cellthe phenotype and the other four Sox2-gRNAs gave no
apparent phenotype. Of 487 eggs injected with Sox2-
gRNA#2, 403 survived, hatched, and grew to normal sizes.
Upon closer visual inspection of behavior, 274 (68%)
showed a curved body (Figure 3C) when swimming, and
many appeared to have excess blood in the olfactory bulb
area (Figure 3C0, red arrow). The same phenotype was
observed from Sox2-gRNA#4-injected animals (Figures 3E
and 3E0). This phenotype was never observed in the GFP-
gRNA#1-injected animals (Figures 3D, 3D0, 3F, and 3F0).
Immunohistological examination of the olfactory bulb
confirmed a severe reduction in SOX2-positive cells at the
lumen of the olfactory bulb and a general loss of cell
number (Figure S1A). The observation of identical pheno-
types from two different Sox2-gRNAs, combined with the
absence of the phenotype in all animals injected with
GFP and Tyrosinase gRNAs, indicates that the phenotypes
are specific to Sox2 deletion and not due to off-target
effects.
The genetic knockout of Sox2 in mice results in preim-
plantation lethality (Avilion et al., 2003), and there-
fore, the survival through embryonic development was
surprising, although knockdown of Sox2 by morpho-
lino in amphibian or fish has not been reported. We
therefore analyzed the penetrance of CRISPR-mediated
Sox2 deletions within individual animals at two develop-
mental stages: embryonic stage 15 (neural plate stage)
and day 13 larvae. At stage 15, when there was no
scorable phenotype, injected animals were randomly
selected and genotyped by PCR. Among this cohort,
4 out of 11 animals yielded 100% of cloned inserts with
deletions in Sox2, indicating that animals can survive to
stage 15 with what appears to be complete penetrance
of Sox2 deletion (Figure S1B). Day 13 larvae could be
phenotypically sorted based on the curved-body pheno-
type (68% of total). Genotyping of the curved-body
animals showed 8 out of 11 animals with 100% of
clones containing deletions in Sox2 (Figures 3G andFP-TALEN #3 by PCR amplification and sequencing of clones. A total
he genomic sequence, reflecting a high rate of genome modification
which >50% of cells have lost GFP expression.
cells are visible (red arrow).
in 50% of the body.
Tyr) gene as a control shows no knockdown of the GFP-transgene.
Tyrosinase knockdown animals counterstained for DAPI and MHC
he GFP-gRNA#3 section. Scale bars, 100 mm.
FP-gRNA#3 by PCR amplification and sequencing of clones. In both
in the genomic sequence, reflecting a high rate of genome modifi-
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Figure 2. Deletions in the Tyr Gene via TALEN or CRISPR Injections
(A) TALEN and CRISPR gRNAs were designed to target the Tyr sequence and RNAs injected into one-cell-stage eggs.
(B and B0) Two representative axolotl larva that had been injected with Tyr-TALEN #4mRNAs in which >50% of cells have lost pigmentation.
Scale bar, 1 mm.
(C and C0) Two representative axolotl larvae injected with left-arm-only TALEN mRNAs show no loss of pigmentation.
(D) Analysis of the genomic target site in two individuals injected with Tyr-TALEN #4 by PCR amplification and sequencing of clones. In
animal 1, seven out of ten clones showed deletions in the genomic sequence, while in animal 2, 11 out of 12 samples showed genomic
modification, suggesting a high rate of modification in this animal.
(E and E0) Two representative axolotl larva that had been injected with Tyr-gRNA#1 in which nearly all (left panel) or >50% (right panel) of
cells have lost pigmentation. Scale bar, 1 mm.
(F and F0) Two representative axolotl larvae injected with control GFP-gRNA#3 show no loss of pigmentation.
(G) Analysis of the genomic target site in two individuals injected with Tyr-gRNA#1 by PCR amplification and sequencing of clones. In
sample 1, all (12 out of 12) clones showed deletions in the genomic sequence, while in animal 2, all (12 out of 12) samples showed the
same genomic modification, suggesting that the deletion was made in the early egg/embryo.
See also Table S4.
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also showed a high-penetrance Sox2 genomic locus
modification (Figure 3H). In contrast, genotyping of
Sox2-gRNA#2-injected animals that did not show the
curved-body/olfactory bulb phenotype showed only a
very low frequency of gene modification (Figure S1D).
These results show that animals harboring a very high
penetrance of CRISPR-mediated Sox2 deletions in the ge-
nomes of their somatic cells can survive embryonic devel-
opment to day 13 larvae.448 Stem Cell Reports j Vol. 3 j 444–459 j September 9, 2014 j ª2014 The ATo confirm our conclusions from the CRISPR-mediated
deletions, we investigated the embryonic phenotype of
knocking down SOX2 protein via injection of fluorescein
isothiocyanate-coupled morpholinos against the Sox2
translational start site into one-cell-stage embryos. Sox2
morpholino or control morpholinos were injected at
three different concentrations (Figure S2A) and yielded an
indistinguishable proportion of viable embryos when
screened at embryonic stage 37 (Figures S2A–S2C). Immu-
nostaining for SOX2 on cross-sections of stage 16/17uthors
Stem Cell Reports
CRISPR-Mediated Sox2 Deletion in Axolotlanimals confirmed downregulation of SOX2 expression in
Sox2 morpholino-injected embryos (Figures S2D and S2E).
The independent knockdown of SOX2 via morpholinos
also revealed no detectable embryonic phenotype, con-
firming the results from CRISPR-mediated Sox2 deletion.
To initially characterize the effects of SOX2 deletion
in the uninjured spinal cord by immunohistochemistry,
we used animals that showed approximately half-body
knockout of SOX2 to have an internal control. Based on
our experience with GFP-CRISPR knockouts, animals can
often show deletion of the gene in one-half of their
body, presumably due to action of the CRISPR in one of
the first two blastomeres during development. When we
analyzed sections of the anterior spinal cord of such ani-
mals, at least one-half of the spinal cord was lacking
SOX2 expression in the cells lining the spinal cord lumen
(Figure 3I). Surprisingly, in such animals, the left and right
side of the spinal cord were similar in size and organiza-
tion, showing NEUN+ neuronal cells at the outer circum-
ference (Figure 3I). We also observed normal expression
of other markers associated with axolotl neural stem cells
in the Sox2-deleted cells, including normal expression of
GFAP and the tight junction protein ZO-1, as well as the
proliferative markers proliferating cell nuclear antigen
(PCNA) and phosphohistone H3 (PH3) (Figures 3J–3L).
We further examined the profile of proliferation markers
by injection of 5-ethynyl-20-deoxyuridine (EdU). In the
uninjured spinal cord, the incorporation of EdU was
similar in the SOX2+ and the SOX2 side of the spinal
cord (Figure 3M).
Defective Spinal Cord Regeneration due to Lack of
Enhanced Proliferation after Tail Amputation in
Sox2-CRISPR Animals
Since the uninjured spinal cord showed normal organiza-
tion under conditions of Sox2 deletion, we went on to
determine if there is a phenotype during tail regeneration.
We amputated the tails of Sox2-CRISPR animals that
showed the curved-body phenotype in order to select for
animals that had ahighpenetrance of deletions (Figure 4A).
We characterized the spinal cords in the removed portion
of the tail next to the amputation plane to determine the
penetrance of SOX2 deletion and the organization of the
spinal cord at the starting point of the regeneration exper-
iment. As expected, most animals showed massive or com-
plete loss of the SOX2 spinal cord immunofluorescence
signal at the amputation plane in the removed portion of
the tail (Figures 4A, 4B, and S1E). Consistent with our
analysis above, we found that the spinal cord size, organi-
zation, and PCNA expression was normal in spinal cords
lacking SOX2+ cells (Figure 4B). PCNA expression in the
uninjured ependymal cells of both control and Sox2-
CRISPR animals showed differential intensity levels thatStem Cellreflect significant G1 and S phases of the slow cell cycle
found in these neural stem cells under homeostatic condi-
tions (A. Rodrigo-Albors, personal communication). We
then examined whether the overall length of the regener-
ated spinal cord and tail was affected by following live
animals at 6 and 10 days after tail amputation under obli-
que transillumination conditions. Animals injected with
Sox2-gRNA#2 or with Sox2-gRNA#4 showed reduced or
lack of spinal cord in the regenerated portion of the tail.
(Figure 4C). In contrast, control GFP-gRNA#1-injected ani-
mals showed clear outgrowth of the spinal cord into the
blastema (Figure 4C). We quantitated this phenotype by
measuring the length of the overall tail regenerate versus
the length of the visible spinal cord (Figure 4A). The overall
tail regenerate length was unaffected in Sox2-CRISPR ani-
mals, while the spinal cord showed a significantly reduced
length resulting in a shifted ratio of spinal cord/tail regen-
erate length (Figures 4D and 4E). We further correlated the
extent of Sox2 deletion found in the removed portion of
the tail (see above) with the spinal cord regeneration
phenotype at 6 days and found that those specimens
showing complete knockout of SOX2 immunofluores-
cence at the amputation plane displayed the strongest spi-
nal cord growth inhibition (Figures S1E and S1F). Analysis
of the live samples at 10 days postamputation showed a
continued defect in spinal cord outgrowth into the blas-
tema (Figures S3A–S3C). By this later time point, a mild
effect on blastema length was observed in some Sox2-
deleted animals.
To characterize the spinal cord regeneration defect in
more detail, we examined immunohistological sections of
the spinal cord at different distances behind the amputa-
tion plane and in the regenerate at 6 and 10days postampu-
tation. Behind the amputation plane, in the region of the
spinal cord that acts as the source zone for the regenerate
(McHedlishvili et al., 2007), the spinal cord showed com-
parable morphology and marker expression to control
animals including robust GFAP expression as well as
neuron-specific tubulin, TUJ1 expression at the outer
circumference (Figures 5A–5D). However, in contrast to
the Sox2-CRISPR spinal cords that prior to amputation
showed normal cell numbers (Figure 5E), in the 6- and 10-
day regenerates, the number of cells per cross-section in
the source zone behind the amputation plane was reduced
compared to control regenerates (M1 and M2; Figures 5F
and S3D). This suggests that cells from the source zone
contribute to the regenerate but are not replenished. The re-
generating region of the spinal cord (R1–R5; Figures 5F and
S3D) showeda starkly reducednumber ofGFAP+ spinal cord
cells, especially inmore distal regions of the regenerate, sug-
gesting a defect in self-renewal and also a disorganization of
TUJ1+ cells (Figures 5A, 5C, and S3E). Interestingly, despite
themajority of the Sox2-gRNA#2-injected animals showingReports j Vol. 3 j 444–459 j September 9, 2014 j ª2014 The Authors 449
(legend on next page)
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amputationplane (Figures 4B, S1C, and S1E), the regenerate
routinely contained some cells that were immunopositive
for SOX2. As described in Sox2 heterozygous knockout
mice, we observed specific, cytoplasmic rather than nuclear
staining in some of the regenerating samples in which the
few remaining SOX2+ cells seem to have contributed to
the regenerated spinal cord (Avilion et al., 2003) (Figures
5C and S3E).
The above phenotype suggested that deletion of Sox2 in
neural stem cells results in a defect in proliferative expan-
sion of neural stem cells specifically after tail amputation.
To gain further insight into these proliferative properties,
we first examined PCNA expression in the 6-day regener-
ated spinal cords. While all cells in the regenerating spinal
cord of Sox2-CRISPR animals were positive for PCNA (Fig-
ure 6A), they showed the varying signal intensities that
were more similar to the slow-cycling, nonregenerating,
control spinal cord cells (Figure 4B) compared to the
more homogeneous staining typical of fast-cycling neural
stem cells in the control regenerates (Figure 6A). This sug-
gested that in Sox2-CRISPR animals, cells do not accelerate
their cell cycle efficiently and possess a significant G1
phase. To corroborate this hypothesis, we performed pulse
labeling with the S phase marker EdU on regeneration day
6 for 3 hr prior to harvesting the tail for immunohisto-
chemical processing. In the Sox2-CRISPR animals, we
observed a marked reduction in the percentage (from
75% to 31%) of TUJ1NEUN spinal cord cells that incor-
porated EdU (Figures 6B and 6C), indicating a decreasedFigure 3. Normal Spinal Cord Organization in Animals with CRISP
(A) Schema depicting the locations of seven and sequence of two CR
(B) Schema illustrating the binding between Sox2-gRNA#2 and the S
(C–F0 0) Representative axolotl larvae that received Sox2-gRNA#2 (C and
bulb defects (C0 and E0, red arrows). Animals receiving control (Ctr) GFP
1 mm in (C) and (E) and 0.5 mm in (C0) and (E0).
(G and H) Analysis of the genomic target site in two (G) or one (H) indi
PCR amplification and sequencing of clones. Note: these individuals
(I) Sox2-CRISPR animals maintain normal organization of neurons.
combined with DAPI (blue) on spinal cord cross-sections from anima
gRNA#1. Two individual spinal cord sections along the anterior-poste
animals are lacking SOX2 protein expression in at least half of the spin
modification at the two-cell stage. Both SOX2+ and SOX2 sides of the
lines indicate spinal cord area; yellow lines indicate apical surface. S
(J and K) Sox2-deleted cells maintain GFAP and ZO-1 expression. Immu
combined with DAPI (blue) from Sox2-gRNA#2-injected animals. Both
GFAP. Square boxes denote insets shown at higher magnification bel
(L) Normal expression of proliferative markers in Sox2-deleted cells.
histone H3 (green) combined with DAPI (blue) on cross-sections. Sc
(M) Incorporation of EdU in Sox2-deleted cells in the uninjured spi
(green) and DAPI (blue) on spinal cord cross-sections from animals i
Scale bar, 50 mm.
See also Figures S1 and S2.
Stem Cellproliferative activity of the stem/progenitor cells. The
timing or duration of the cell cycle in neural progenitors
can be modulated at various phases of the cell cycle,
including the Gap phases as well as S phase (Arai et al.,
2011). We examined whether S phase may have slowed
down in the Sox2-depleted cycling cells but found no evi-
dence for a change in average EdU fluorescence intensity
(Figure 6D and 6E), suggesting that the S phase properties
were not altered but rather a higher percentage of cells re-
mained in G1 or G2/M in the Sox2-CRISPR animals. These
results indicate that lack of SOX2 results in a hampered pro-
liferation and expansion of the neural stem/progenitor cell
pool without changing a number of key markers of radial
glial cell identity.
Downregulation of Sox3 during Spinal Cord
Regeneration
Considering the survival of Sox2-CRISPR animals through
embryonic development but the strong regeneration-spe-
cific phenotype, we turned to Sox3 as a potential family
member whose expressionmay rationalize the Sox2 depen-
dence of regeneration, but not development. In frog and
fish embryos, Sox3, whose overexpression caused expan-
sion of the CNS and whose knockdown caused reduction
of CNS tissue, was shown to control Sox2 expression, but
not vice versa (Dee et al., 2008; Rogers et al., 2009). No
phenotype for Sox2 knockdown in these models was
described. Sox2 deletion in the mouse CNS showed a mild
phenotype, with a compensatory upregulation of Sox3
(Miyagi et al., 2008). We therefore examined expressionR-Mediated Deletions in the Sox2 Locus
ISPR gRNAs designed against the Sox2 coding sequence.
ox2 target sequence.
C0) and Sox2-gRNA#4 (E and E0) show curved body and/or olfactory
-gRNA#1 show no such defects (D, D0, F, and F0). Scale bars represent
viduals injected with Sox2-gRNA#2 or Sox2-gRNA#4, respectively, by
show a very high proportion of clones with modification.
Immunofluorescence staining for SOX2 (red) and NEUN (green)
ls injected with Sox2-gRNA#2 (upper panels) or control (Ctr) GFP-
rior axis are shown. A significant number of Sox2-gRNA#2-injected
al cord indicating biallelic loss in one-half of the body, suggesting
spinal cord have NEUN+ neurons at the outer circumference. Dashed
cale bars, 50 mm.
nofluorescence for SOX2 (red) and GFAP (green, J) or ZO-1 (green, K)
the side with SOX2+ cells and the side without SOX2+ cells express
ow. Scale bars, 50 mm.
Immunofluorescence for SOX2 (red), PCNA (white), and phospho-
ale bar, 50 mm.
nal cord. Immunofluorescence for SOX2 (red) combined with EdU
njected with Sox2-gRNA#2, with 3 hr EdU labeling before harvest.
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CRISPR-Mediated Sox2 Deletion in Axolotlof the axolotl Sox3 gene during development and tail
regeneration. Whole-mount in situ hybridization of
axolotl embryos at stages 15, 17, 34, and 37 showed indis-
tinguishable Sox2 and Sox3 expression in the CNS,
including the spinal cord all along the body axis (Figures
7A and 7B). This finding most likely explains the lack of
embryonic phenotype in animals with reduced SOX2
either by CRISPR- or morpholino-mediated knockdown.
When we checked Sox3 expression during spinal cord
regeneration by quantitative PCR and by in situ hybridiza-
tion of longitudinal sections at day1 and day 6, we
observed a specific downregulation of Sox3 in the regener-
ating portion of the spinal cord (Figures 7C–7E). These re-
sults would correspond to a heightened sensitivity of the
regenerating spinal cord to Sox2 deletion compared to the
developing spinal cord.DISCUSSION
This work represents a number of important advances for
the study of axolotl regeneration. First, we have shown
for several genomic loci that TALENs and CRISPRs can
induce targeted deletions in a large proportion of cells
from injected animals. In all cases, CRISPRs yielded higher
viability of injected animals and higher penetrance of the
phenotype, reflecting deletion of both alleles within often
a large majority of the cells. The Tyr and Sox2 experiments
show strong cellular phenotypes associated with homozy-
gous gene deletion. In addition, for the GFP-transgene,
we have shown germline transmission of the deletion after
TALEN-mediated gene deletion. We therefore conclude
that CRISPRs will be an important mode of generatingFigure 4. Deficient Spinal Cord Regeneration in Sox2-CRISPR Ani
(A) Cartoon illustrates regeneration experimental scheme. Amp, amp
‘M’, mature spinal cord area; ‘R’, regenerated area. Dashed line indicate
(B) Immunofluorescence for SOX2 (red) and PCNA (green) combined w
at the amputation plane (‘A’ in A) from animals injected with Sox2-g
sections from the same animal; one shows complete loss of the SOX2-
positive cell (arrow). Scale bar, 50 mm.
(C) Images of live, 6-day regenerates. Left: Sox2-gRNA#2; middle: S
larger-magnification images of regenerating spinal cord area. In anim
(middle lower panels), a clear spinal cord tube that extends into the bl
‘M’, mature spinal cord area; ‘R’, regenerated area. Dashed lines repre
panel and 200 mm in the lower panel.
(D) Quantitation of spinal cord and tail length in CRISPR Sox2-gRNAs v
Regenerated tail length was indistinguishable between the Sox2-gRN
(n = 12) animals. In contrast, Sox2-gRNAs-injected animals showed a
one individual animal. Error bars, SD; ***p < 0.001.
(E) Spinal cord length to tail length ratio in 6-day regenerates. The spi
gRNA-injected animals compared to controls. The same data set from (
animal. Error bars, SD; ***p < 0.001.
See also Figure S3.
Stem Cellgene deletions and other genome modifications in the
axolotl for regeneration studies.
Our work examining CRISPR-mediated Sox2 deletion
showedmild phenotypes during development but a strong
inhibition of spinal cord regeneration after tail amputa-
tion. The lack of a developmental phenotype due to
SOX2 knockdown was corroborated by the injection of
anti-Sox2morpholinos that knocked down SOX2 immuno-
staining in the embryo but yielded the same frequency of
normally developing embryos as control-injected cohorts.
It is interesting that no knockdown experiments for Sox2
have been reported in amphibian and zebrafish embryos,
raising the possibility that in these vertebrates, Sox2 is
either not solely responsible for maintenance of pluripo-
tent cells or that maternal stores allow survival through
early stages. Indeed, when we examined Sox3, its distribu-
tion overlapped with Sox2 expression in the embryo, sug-
gesting it can compensate for lack of Sox2, especially since
Sox3has been shown to be upstreamof Sox2 inXenopus em-
bryos (Rogers et al., 2009). During regeneration, axolotl
Sox3 was downregulated in the spinal cord, which would
be consistent with an enhanced sensitivity of the regen-
erate to Sox2 knockdown.
Our analysis of tail regeneration in the Sox2-CRISPR ani-
mals showed that despite maintaining a number of radial
glial cell markers, Sox2-deleted spinal cord shows defective
proliferation of GFAP-positive cells and therefore, reduced
outgrowth of the spinal cord at 6 and 10 days postamputa-
tion. In other work, we have defined the cell-cycle charac-
teristics of SOX2+PCNA+-positive cells before and after
regeneration and found that in the uninjured state, resi-
dent cells cycle slowly, on average once every 14 days.
Upon tail amputation, the cell cycle accelerates to a 4-daymals
utation; dpa, day post amputation; ‘A’, amputated spinal cord site;
s the amputation plane, the tip of the spinal cord, and tip of the tail.
ith DAPI (blue) on cross-sections from the removed piece of tail just
RNA#2 or GFP-gRNA#3. Upper and middle panels are two adjacent
positive signal, but the other shows the presence of a single Sox2-
ox2-gRNA#4; right: control (Ctr), GFP-gRNA#3. Lower panels show
als injected with Sox2-gRNA#2 (left lower panels) and Sox2-gRNA#4
astema is not visible compared to the control sample (GFP-gRNA#3).
sent amputation planes. Scale bars represent 500 mm in the upper
ersus control GFP-gRNA-injected animals at 6 days of regeneration.
A#2- (n = 23), Sox2-gRNA#4- (n = 24), and GFP-gRNA#3-injected
significantly shorter spinal cord outgrowth. Each bullet represents
nal cord represents a smaller fraction of the total tail length in Sox2-
D) was used for data plotting. Each bullet represents one individual
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CRISPR-Mediated Sox2 Deletion in Axolotlcycle (A. Rodrigo-Albors, personal communication). Given
that the SOX2TUJ1NEUN cells at the amputation
plane maintained expression of PCNA and normal levels
of EdU incorporation before regeneration, we interpret
this result to mean that the SOX2+ cells that would nor-
mally accelerate their cell cycle are, in the absence of
SOX2, unable to accelerate their cell cycle in response to
injury cues. The role of SOX2 in promoting proliferation
of neural stem/progenitor cells has previously been docu-
mented in the brain and in CNS tumors (Favaro et al.,
2009, 2014), and our work would support a role for SOX2
in injury mediated rapid cell cycles required to expand
the pool of neural stem cells to reconstitute the missing
spinal cord.EXPERIMENTAL PROCEDURES
For further details, see the Supplemental Experimental Procedures.
All other methods were performed according to standard
protocols.
CRISPR Design and RNA Synthesis
For better comparison, relevant TALENs and CRISPRs were de-
signed against the identical sequence of each targeted gene locus.
The design and RNA synthesis were carried out according to the
published protocols (Bedell et al., 2012; Cermak et al., 2011;
Hwang et al., 2013).
Axolotl Care and Egg Injection
Animal experiments were carried out according to German animal
welfare legislation. Axolotl egg injection was performed accord-
ing to previously published protocols (Khattak et al., 2014).
Briefly, 125–500 pg TALEN mRNAs, 500–1,000 pg CRISPR RNAs,
or 5–20 pmol of morpholinos was injected into freshly laid
single-cell-stage embryos. For TALEN- and CRISPR-mediated GFP
knockout experiments, eggs derived from the breeding of hetero-Figure 5. Cellular Analysis of Spinal Cord Regeneration defect in
The defect in the regenerating spinal cord was investigated by immuno
the length of the regenerating spinal cord starting behind the amput
(A and B) Immunostaining for SOX2 (red) and GFAP (green) with DAP
similar morphology between the Sox2-gRNA#2- and GFP-gRNA#3-injec
there are fewer cells in the spinal cord of the Sox2-gRNA#2-injected a
in the regenerating portion of the spinal cord. B, boundary between
(C and D) Immunostaining for SOX2 (red) and TUJ1 (green) with DAPI
the mature portion of the Sox2-gRNA#2- and GFP-gRNA#3-injected an
disorganized in the mid portion of the Sox2-gRNA#2-injected animal
(E) Quantification of the number of nuclei in the intact spinal cord s
spinal cord cells to control (Ctr), GFP-gRNA#3-injected animals. Data
seven Sox2-gRNA#2 animals (each determinant is the average value o
bars, SD.
(F) Quantification of the number of nuclei in the regenerating spina
decreases markedly along the length of the regenerate in Sox2-gRNA#
gRNA#3-injected animals. Data are the mean value of determinants
determinant is the average value of three sections, with 50 mm dista
Stem Cellzygous GFP-transgenic and white axolotl animals were used for in-
jection. For other experiments, eggs derived from either wild-type
or white animals were used for injection. Axolotl larvae were kept
individually in plastic cups with a change of fresh tap water every
second day and fed Artemia daily. Axolotl larvae were anaesthe-
tized within 0.01% ethyl-p-aminobenzoate (benzocaine; Sigma)
prior to imaging or amputation.DNA Extraction, Genotyping, and Sequencing
Genomic DNA extraction and PCR were carried out using
REDExtract-N-Amp Tissue PCR Kit (Sigma) according to themanu-
facturer’s instructions. Each genomic locus was PCR amplified
with gene-specific primer pairs (see the Supplemental Experi-
mental Procedures). The resulting PCR products were cloned into
pGEMT vector (Promega). Individual clones were sequenced with
T7 primer.Microscopy, Quantifications, and Statistics
Fluorescence images were acquired with a Zeiss Observer or
confocal microscope. Bright-field or color images were acquired
with an Olympus dissecting microscope. The length of the regen-
erated spinal cords and tails was measured with CellSens Standard
software. Spinal cord cells were counted using Photoshop soft-
ware. EdU+TUJ1NEUN cells, within 300 mm of amputation
plane, in the regenerated spinal cord were used for quantifica-
tion in Figure 4C. EdU fluorescence intensity (in Figure 4E)
was measured with Software Image J, restricted to the spinal
cells expressing overall EdU (TUJ1, NEUN) versus epidermal
cells expressing overall EdU. The punctate EdU-labeled cells
were most likely excluded because they were at either the begin-
ning or the end of S phase during EdU pulse. After subtracting
the background value, the relative EdU intensity was calculated
by dividing the average EdU intensity value of each individual
spinal cord cell with the average EdU intensity value, minimally
derived from five epidermal cells of the same section. Data plot-
ting was carried out using Microsoft Excel and Prism. Student’s
t test was used for the p value calculation.Sox2-CRISPR Animals
fluorescence staining of cross-sections at different locations along
ation plane.
I shows that while the spinal cord in the mature region (M) shows
ted animals, in the middle region of the regeneration blastema (R),
nimals. Interestingly, some cells showing SOX2 staining are evident
mature and regenerate. Scale bars, 50 mm.
(blue) shows the comparable organization of neurons and axons in
imals. In contrast, the distribution of TUJ1+ cells is scattered and
s.
hows that Sox2-gRNA#2-injected animals have similar numbers of
are the mean value of determinants derived from four control and
f at least three adjacent sections close to amputation plane). Error
l cord at different points along its length shows that cell number
2-injected animals while it stays relatively constant in control GFP-
derived from four control and seven Sox2-gRNA#2 animals (each
nce). Each bar on the x axis stands for 150 mm. Error bars, SD.
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Figure 6. Reduced Proliferative Capacity of Regenerating Spinal Cord Cells in Sox2-CRISPR Animals
(A) Immunostaining for SOX2 (red) and PCNA (green) with DAPI (blue) shows that essentially all cells in the regenerating portion of Sox2-
CRISPR animals at 6 dpa show PCNA staining (dotted lines). However, the heterogeneity in PCNA intensity levels more closely resembles
the profile seen in an unamputated spinal cord (see Figure 4B) compared to the more uniform staining observed in a control regenerating
spinal cord (Ctr). Scale bar, 50 mm.
(B) EdU incorporation was assayed to interrogate passage through the cell cycle. After a 3 hr EdU pulse, cells in the regenerating portion
of the Sox2-gRNA#2-injected animals showed fewer EdU+ cells in the spinal cord (dotted lines) compared to GFP-gRNA#3-injected
control (Ctr) animals. In contrast, the amount of EdU incorporation in epidermis (box) was similar between the two types of animals.
Scale bar, 50 mm.
(legend continued on next page)
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Figure 7. Sox3 Expression Overlaps with Sox2 during Development, but Not Regeneration
(A and B) Sox2 (A) and Sox3 (B) whole-mount in situ hybridization of axolotl embryos at stage 15, 17, 34, and 37. Note the indistin-
guishable Sox2 and Sox3 expression in the CNS, including the spinal cord, at all stages analyzed. Sox2, but not Sox3, is also expressed in the
lateral line (red arrow) and cloaca (black arrow) at stage 37. Scale bars represent 1 mm in (A), left panels and 0.5 mm in (A), lower right
panel.
(C) Sox3 in situ hybridization of a 1-day regenerating tail, longitudinal section. Sox3 expression is reduced in the 500 mm zone next to the
amputation plane that will be the source of the regenerating spinal cord.
(D) Sox3 in situ hybridization of a 6-day regenerating tail, longitudinal section. Sox3 expression is low all along the regenerating portion
of the spinal cord. SC, spinal cord; NC, nodal cord; M, mature; R, regenerate. Dashed lines represent amputation planes. Scale bar, 200 mm.
(E) Results of quantitative RT-PCR of Sox2 and Sox3 expression in the 500 mm response zone next to the amputation plane at 1 dpa as shown
in (C) versus the 500 mm developing tail portion adjacent to the amputation plane at the day of amputation (0 dpa). Data are derived from
three individual experiments and expressed as ratio of gene expression level in the response/nonresponse zone, with the ratio obtained in
the case of control EF1 being set as1 and the ratios obtained in Sox2 and Sox3 being expressed relative to it. Error bars, SD; **p < 0.01.
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The GenBank accession numbers for the Sox2 and Sox3 sequences
reported in this paper are KJ999995 and KJ999996, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, three figures, and four tables and can be found(C) Quantification of EdU+ (TUJ, NEUN) spinal cord cells as shown in
plane. Cells from Sox2-gRNA-injected animals showed a 31% incorpora
In total, 429 and 237 spinal cord cells, from ten Sox2-gRNA#2- and fou
data plotting. Error bars, SD.
(D) Quantification of the distribution of EdU nuclear staining pattern
‘‘punctate’’ versus ‘‘overall’’ EdU label. Data derived from three Sox2-gR
plotting.
(E) Quantification of the EdU intensity in spinal cord cells shows simil
animals, S phase still progresses at a similar rate to controls, but more
cells shown in (D), derived from three Sox2-gRNA#2- and two GFP-gRN
Stem Cellwith this article online at http://dx.doi.org/10.1016/j.stemcr.
2014.06.018.
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